Vanguard Group Inc Amgen Inc Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Amgen Inc stock. As of the latest transaction made, Vanguard Group Inc holds 53,711,570 shares of AMGN stock, worth $15.9 Billion. This represents 0.25% of its overall portfolio holdings.

Number of Shares

53,711,570

Previous 52,870,453 1.59%

Holding current value

$15.9 Billion

Previous $16.5 Billion 8.95%

% of portfolio

0.25%

Previous 0.31%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$262.28 - $309.85 $221 Million - $261 Million	841,117 Added 1.59%	53,711,570 $15 Billion
Q1 2025 May 09, 2025	BUY	$258.59 - $327.36 $38.4 Million - $48.7 Million	148,658 Added 0.28%	52,870,453 $16.5 Billion
Q4 2024 Feb 11, 2025	BUY	$258.78 - $328.31 $87.9 Million - $111 Million	339,522 Added 0.65%	52,721,795 $13.7 Billion
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $157 Million - $172 Million	508,907 Added 0.98%	52,382,273 $16.9 Billion
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $56.5 Million - $68.6 Million	-214,844 Reduced 0.41%	51,873,366 $16.2 Billion
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $819 Million - $988 Million	3,045,657 Added 6.21%	52,088,210 $14.8 Billion
Q4 2023 Mar 11, 2024	BUY	$255.7 - $288.46 $1.6 Million - $1.8 Million	6,242 Added 0.01%	49,042,553 $14.1 Billion
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $84,381 - $95,191	330 Added 0.0%	49,036,311 $14.1 Billion
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $36.2 Million - $45 Million	165,636 Added 0.34%	49,035,981 $13.2 Billion
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $8.76 Million - $10.4 Million	40,885 Added 0.08%	48,870,345 $10.9 Billion
Q1 2023 Jul 14, 2023	BUY	$225.79 - $275.2 $1.4 Million - $1.71 Million	6,209 Added 0.01%	48,829,460 $11.8 Billion
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $171 Million - $209 Million	758,112 Added 1.58%	48,823,251 $11.8 Billion
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $139 Million - $176 Million	605,628 Added 1.28%	48,065,139 $12.6 Billion
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $294 Million - $332 Million	1,310,894 Added 2.84%	47,459,511 $10.7 Billion
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $272 Million - $303 Million	-1,180,428 Reduced 2.49%	46,148,617 $11.2 Billion
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $146 Million - $162 Million	668,036 Added 1.43%	47,329,045 $11.4 Billion
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $27.1 Million - $31 Million	-136,233 Reduced 0.29%	46,661,009 $10.5 Billion
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $66.6 Million - $78 Million	-313,630 Reduced 0.67%	46,797,242 $9.95 Billion
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $11 Billion - $12.2 Billion	47,110,872 New	47,110,872 $11.5 Billion

Others Institutions Holding AMGN

# of Institutions

3,282

Shares Held

441M

Call Options Held

6.14M

Put Options Held

7.25M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Amgen Inc Transaction History